2seventy bio
TSVT
TSVT was delisted on the 13th of May, 2025.
115 hedge funds and large institutions have $213M invested in 2seventy bio in 2024 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 37 reducing their positions, and 12 closing their positions.
695% more call options, than puts
Call options by funds: $739K | Put options by funds: $93K
16% more capital invested
Capital invested by funds: $183M → $213M (+$29.3M)
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
0% more funds holding
Funds holding: 115 → 115 (0)
30% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 37
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WSL
Western Standard LLC
Los Angeles,
California
|
+$1.29M |
| 2 |
BlackRock
New York
|
+$943K |
| 3 |
BP
BBR Partners
New York
|
+$699K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$645K |
| 5 |
Goldman Sachs
New York
|
+$370K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$3.96M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.05M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.9M |
| 4 |
Morgan Stanley
New York
|
-$1.71M |
| 5 |
Millennium Management
New York
|
-$1.45M |
TSVT Hedge Fund Activity: Q3 2024 in Review
115 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q3 2024, worth a combined $213M — up 16% from $183M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new TSVT positions and 12 closed out — a net gain of 1 holder — while 26 added to existing stakes and 37 trimmed.
The largest buyer was Western Standard LLC, opening a new position worth an estimated $1.29M. The largest seller was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, cutting an estimated $3.96M.
- 115 institutional investors held 2seventy bio (TSVT) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $213M of 2seventy bio stock for Q3 2024, up 16% quarter-over-quarter.
- 13 funds opened new 2seventy bio positions in Q3 2024 and 12 closed out, a net change of +1 holder.
- The largest 2seventy bio buyer in Q3 2024 was Western Standard LLC, an estimated $1.29M added.
- The largest 2seventy bio seller in Q3 2024 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $3.96M sold.
Based on aggregated 13F filings for Q3 2024.